Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1588-1593
Published online before print June 9, 2005, doi: 10.1161/01.STR.0000170642.39876.f2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/7/1588    most recent
01.STR.0000170642.39876.f2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hart, R. G.
Right arrow Articles by Pearce, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hart, R. G.
Right arrow Articles by Pearce, L. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLSALICYLIC ACID
*WARFARIN
Related Collections
Right arrow Anticoagulants
Right arrow Antiplatelets
Right arrow Coumarins

(Stroke. 2005;36:1588.)
© 2005 American Heart Association, Inc.


Comments, Opinions, and Reviews

Avoiding Central Nervous System Bleeding During Antithrombotic Therapy

Recent Data and Ideas

Robert G. Hart, MD; Silvina B. Tonarelli, MD Lesly A. Pearce, MS

From Department of Medicine (Neurology; R.G.H., S.B.T.), University of Texas Health Science Center, San Antonio; Minot (L.A.P.), ND.

Correspondence to Robert G. Hart, MD, Department of Medicine (Neurology), University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive MC 7883, San Antonio, TX 78229-3900. E-mail hartr{at}uthscsa.edu

Background— Approximately 7000 intracerebral hemorrhages (ICHs) annually in the US are caused by use of antithrombotic therapies. We review the incidence, risk factors, and predictors of ICH in patients receiving long-term anticoagulation or antiplatelet therapy.

Summary of Review— ICH rates range from 0.3% to 0.6% per year during oral anticoagulation in recent reports. Major risk factors are advanced patient age, elevated blood pressure, intensity of anticoagulation, and previous cerebral ischemia. Combining antiplatelet agents with anticoagulation and the combined use of aspirin plus clopidogrel appear to increase ICH risk. Modest blood pressure-lowering halves the frequency of ICH during antiplatelet therapy.

Conclusion— ICH is an uncommon, but often fatal, complication of antithrombotic therapy that particularly afflicts patients with previous stroke. Recent data support that keeping international normalized ratio ≤3.0, control of hypertension, and avoiding the combination of aspirin with warfarin reduce its frequency.


Key Words: anticoagulants • antiplatelet • antithrombotic therapy • aspirin • clopidogrel • intracerebral hemorrhage • warfarin




This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
C. L Garwood and T. L Corbett
Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls
Ann. Pharmacother., April 1, 2008; 42(4): 523 - 532.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Doufekias, A. Z. Segal, and J. R. Kizer
Cardiogenic and aortogenic brain embolism.
J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1049 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
N U Weir
An update on cardioembolic stroke
Postgrad. Med. J., March 1, 2008; 84(989): 133 - 142.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
E. M. Hylek and D. E. Solarz
Dual Antiplatelet and Oral Anticoagulant Therapy: Increasing Use and Precautions for a Hazardous Combination
J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 62 - 64.
[Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
N. A. Nickman, J. Biskupiak, F. Creekmore, H. Shah, and D. I . Brixner
Antiplatelet medication management in patients hospitalized with ischemic stroke
Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2250 - 2256.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al.
REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Circulation, October 16, 2007; 116(16): e391 - e413.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. H. Falk
Ethnic Disparity in Intracranial Hemorrhage Among Anticoagulated Patients With Atrial Fibrillation: An Answer in Search of a Question?
J. Am. Coll. Cardiol., July 24, 2007; 50(4): 316 - 318.
[Full Text] [PDF]


Home page
StrokeHome page
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al.
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Stroke, June 1, 2007; 38(6): 2001 - 2023.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. M. Hylek, C. Evans-Molina, C. Shea, L. E. Henault, and S. Regan
Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation
Circulation, May 29, 2007; 115(21): 2689 - 2696.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. B. Gorelick
Combining Aspirin With Oral Anticoagulant Therapy: Is This a Safe and Effective Practice in Patients With Atrial Fibrillation?
Stroke, May 1, 2007; 38(5): 1652 - 1654.
[Full Text] [PDF]


Home page
Eur Heart JHome page
G. Y.H. Lip, L. Frison, M. Grind, and on behalf of the SPORTIF Investigators
Effect of hypertension on anticoagulated patients with atrial fibrillation
Eur. Heart J., March 2, 2007; 28(6): 752 - 759.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. L. Flaherty, B. Kissela, D. Woo, D. Kleindorfer, K. Alwell, P. Sekar, C. J. Moomaw, M. Haverbusch, and J. P. Broderick
The increasing incidence of anticoagulant-associated intracerebral hemorrhage
Neurology, January 9, 2007; 68(2): 116 - 121.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
L Kalra, G Y H Lip, and on behalf of the Guideline Development Group for t
Antithrombotic treatment in atrial fibrillation
Heart, January 1, 2007; 93(1): 39 - 44.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
A. Nair, B. Sealove, J. L. Halperin, G. Webber, and V. Fuster
Anticoagulation in patients with heart failure: who, when, and why?
Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E32 - E38.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): 700 - 752.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030.
[Full Text] [PDF]